South Korea
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
40.38%
|
Dec. 31, 2023 | USD 5.74 | 1.22% |
|
South Korea |
|
2 |
34.26%
|
Dec. 31, 2023 | USD 7.27 | 1.40% |
|
South Korea |
|
3 |
25.85%
|
Dec. 31, 2023 | USD 13.91 | 0.99% |
|
South Korea |
|
4 |
23.54%
|
Dec. 31, 2023 | USD 69.36 | 0.94% |
|
South Korea |
|
5 |
23.06%
|
Dec. 31, 2023 | USD 52.79 | -1.92% |
|
South Korea |
|
6 |
18.61%
|
Dec. 31, 2023 | USD 15.35 | 2.10% |
|
South Korea |
|
7 |
17.64%
|
Dec. 31, 2023 | USD 35.40 | 0.74% |
|
South Korea |
|
8 |
17.31%
|
Dec. 31, 2023 | USD 53.54 | 0.36% |
|
South Korea |
|
9 |
17.00%
|
Dec. 31, 2023 | USD 11.71 | 0.86% |
|
South Korea |
|
10 |
16.59%
|
Dec. 31, 2023 | USD 27.25 | 1.12% |
|
South Korea |
|
11 |
15.96%
|
Dec. 31, 2023 | USD 5.33 | 3.12% |
|
South Korea |
|
12 |
15.89%
|
Dec. 31, 2023 | USD 59.95 | 0.74% |
|
South Korea |
|
13 |
15.76%
|
Dec. 31, 2023 | USD 211.76 | 1.06% |
|
South Korea |
|
14 |
13.29%
|
Dec. 31, 2023 | USD 12.37 | 2.38% |
|
South Korea |
|
15 |
12.84%
|
Dec. 31, 2023 | USD 166.75 | 2.20% |
|
South Korea |
|
16 |
12.47%
|
Dec. 31, 2023 | USD 6.84 | 1.45% |
|
South Korea |
|
17 |
11.71%
|
Dec. 31, 2023 | USD 29.29 | 1.09% |
|
South Korea |
|
18 |
11.69%
|
Dec. 31, 2023 | USD 2.90 | 1.70% |
|
South Korea |
|
19 |
11.29%
|
Dec. 31, 2023 | USD 28.71 | -0.56% |
|
South Korea |
|
20 |
10.82%
|
Dec. 31, 2023 | USD 3.37 | 1.25% |
|
South Korea |
|
21 |
10.23%
|
Dec. 31, 2023 | USD 97.87 | 1.09% |
|
South Korea |
|
22 |
9.69%
|
Dec. 31, 2023 | USD 62.74 | 1.29% |
|
South Korea |
|
23 |
9.65%
|
Dec. 31, 2023 | USD 148.68 | -0.63% |
|
South Korea |
|
24 |
9.39%
|
Dec. 31, 2023 | USD 2.54 | 1.01% |
|
South Korea |
|
25 |
8.91%
|
Dec. 31, 2023 | USD 8.16 | 0.82% |
|
South Korea |
|
26 |
8.71%
|
Dec. 31, 2023 | USD 19.23 | 2.19% |
|
South Korea |
|
27 |
8.66%
|
Dec. 31, 2023 | USD 23.19 | 0.44% |
|
South Korea |
|
28 |
8.51%
|
Dec. 31, 2023 | USD 8.84 | 0.74% |
|
South Korea |
|
29 |
7.64%
|
Dec. 31, 2023 | USD 49.17 | -4.18% |
|
South Korea |
|
30 |
7.60%
|
Dec. 31, 2023 | USD 3.20 | 1.71% |
|
South Korea |
|
31 |
7.54%
|
Dec. 31, 2023 | USD 0.87 | 2.19% |
|
South Korea |
|
32 |
7.31%
|
Dec. 31, 2023 | USD 12.38 | 0.79% |
|
South Korea |
|
33 |
7.13%
|
Dec. 31, 2023 | USD 5.39 | 3.62% |
|
South Korea |
|
34 |
7.10%
|
Dec. 31, 2023 | USD 13.38 | 2.30% |
|
South Korea |
|
35 |
6.87%
|
Dec. 31, 2023 | USD 33.66 | 0.23% |
|
South Korea |
|
36 |
6.60%
|
Dec. 31, 2023 | USD 1.94 | 0.04% |
|
South Korea |
|
37 |
6.03%
|
Dec. 31, 2023 | USD 46.31 | 1.79% |
|
South Korea |
|
38 |
5.88%
|
Dec. 31, 2023 | USD 43.58 | 6.40% |
|
South Korea |
|
39 |
5.84%
|
Dec. 31, 2023 | USD 43.24 | -0.21% |
|
South Korea |
|
40 |
5.82%
|
Dec. 31, 2023 | USD 24.28 | -0.66% |
|
South Korea |
|
41 |
5.47%
|
Dec. 31, 2023 | USD 5.19 | -2.34% |
|
South Korea |
|
42 |
5.45%
|
Dec. 31, 2023 | USD 8.54 | 1.06% |
|
South Korea |
|
43 |
5.41%
|
Dec. 31, 2023 | USD 39.56 | 2.33% |
|
South Korea |
|
44 |
5.25%
|
Dec. 31, 2023 | USD 20.53 | 0.24% |
|
South Korea |
|
45 |
5.24%
|
Dec. 31, 2023 | USD 29.16 | 0.39% |
|
South Korea |
|
46 |
5.14%
|
Dec. 31, 2023 | USD 86.75 | 2.10% |
|
South Korea |
|
47 |
5.13%
|
Dec. 31, 2023 | USD 17.29 | -0.83% |
|
South Korea |
|
48 |
4.95%
|
Dec. 31, 2023 | USD 58.17 | 3.28% |
|
South Korea |
|
49 |
4.91%
|
Dec. 31, 2023 | USD 5.03 | 5.45% |
|
South Korea |
|
50 |
4.25%
|
Dec. 31, 2023 | USD 10.03 | 3.70% |
|
South Korea |
The Petrochemicals company in South Korea with the highest EBITDA Margin is KSS Line Ltd. (KSE: 044450.KS) at 40.38%.
The Petrochemicals company in South Korea with the lowest EBITDA Margin is Aprogen Medicines Inc. (KSE: 007460.KS) at -43.52%.
The top 10 Petrochemicals companies in South Korea by EBITDA Margin are KSS Line Ltd., Taekyung Chemical Co., Ltd., Tae Kwang Corporation, Hansol Chemical Co., Ltd., OCI Company Ltd., Dongjin Semichem Co., Ltd., KPX Holdings Co.,Ltd., Miwon Chemicals Co., Ltd., TKG Huchems Co.,Ltd. and LOTTE Fine Chemical Co., Ltd..
The bottom 10 Petrochemicals companies in South Korea by EBITDA Margin are Aprogen Medicines Inc., Kumyang Co., Ltd., FutureChem Co.,Ltd, ChinYang Chemical Corporation, Foosung Co., Ltd., Taekwang Industrial Co., Ltd., ISU Chemical Co., Ltd, Hyosung Chemical Corporation, Namhae Chemical Corporation and GS Global Corp..